EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.26 | Carcinoma |
7016920 |
A factor X-activating cysteine protease from malignant tissue. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 1 4 1 |
3.4.22.26 | Neoplasms |
7016920 |
A factor X-activating cysteine protease from malignant tissue. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 1 4 1 |
3.4.22.26 | Leukemia |
3355894 |
A new procoagulant in acute leukemia. |
causal interaction diagnostic usage ongoing research unassigned |
1 1 4 0 |
3.4.22.26 | Neoplasms |
3355894 |
A new procoagulant in acute leukemia. |
causal interaction diagnostic usage ongoing research unassigned |
1 1 4 0 |
3.4.22.26 | Carcinoma |
7016982 |
A proteolytic procoagulant associated with malignant transformation. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 4 1 |
3.4.22.26 | Neoplasms |
7016982 |
A proteolytic procoagulant associated with malignant transformation. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 4 1 |
3.4.22.26 | Breast Neoplasms |
10656610 |
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients. |
diagnostic usage therapeutic application unassigned |
4 1 0 |
3.4.22.26 | Neoplasms |
10656610 |
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients. |
diagnostic usage therapeutic application unassigned |
4 1 0 |
3.4.22.26 | Neoplasms |
9466566 |
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 4 1 |
3.4.22.26 | Lung Neoplasms |
9241361 |
Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum. |
diagnostic usage ongoing research unassigned |
4 4 0 |